Contact

Jamie Lacey-Moreira, PressComm PR Principal & Founder

Are you ready to give your communications strategy a new perspective? The PressComm PR team works with life science and health care organizations, delivering a flexible, resource-leveraging communications program.

Please contact Jamie to let us know how we can help your organization:

Jamie Lacey-Moreira, Principal
PressComm PR, LLC
Ph: 410.299.3310
Email: jamielacey@presscommpr.com

News

September 7, 2021

National Cancer Institute (NCI) Awards Isoprene Pharmaceuticals, Inc. a Two-Year $2 Million Small Business Innovation Research (SBIR) Grant
University of Maryland, Baltimore (UMB) startup is part of University's New Ventures Initiative, a highly selective program that works to accelerate commercialization and exit strategies [Read More]
August 19, 2021

Empower Therapeutics Inc. Granted Exclusive License to Develop Digital Therapeutics Platform for Neuromodulation of Pain Sensitivity
Technology developed by scientists at the University of Maryland, Baltimore (UMB) and the University of Birmingham, U.K. BALTIMORE, Aug. 19, 2021 /PRNewswire/ -- Empower Therapeutics Inc., a Baltimore-based startup, [Read More]
August 16, 2021

Sagimet Biosciences Doses First Patient in FASCINATE-2 Phase 2b Trial in NASH Patients with Moderate to Advanced Fibrosis
FOR IMMEDIATE RELEASE San Mateo, California, August 16, 2021 – Sagimet Biosciences, a clinical-stage biotechnology company focused on developing a portfolio of internally-discovered, selective fatty acid [Read More]

PressComm

Contact

Contact

Site Links

Social

About PressComm PR